A phase I trial of interleukin 3 (IL-3) pre-bone marrow harvest with granulocyte-macrophage colony-stimulating factor (GM-CSF) post-stem cell infusion in patients with solid tumors receiving high-dose combination chemotherapy.

MLA

Sosman, J. A., et al. “A Phase I Trial of Interleukin 3 (IL-3) Pre-Bone Marrow Harvest with Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Post-Stem Cell Infusion in Patients with Solid Tumors Receiving High-Dose Combination Chemotherapy.” Bone Marrow Transplantation, vol. 16, no. 5, Nov. 1995, pp. 655–61. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=8547862&authtype=sso&custid=ns315887.

APA

Sosman, J. A., Stiff, P. J., Bayer, R. A., Peliska, J., Peace, D. J., Loutfi, S., Stock, W., Oldenburg, D., Unverzagt, K., Bender, J., & et. al. (1995). A phase I trial of interleukin 3 (IL-3) pre-bone marrow harvest with granulocyte-macrophage colony-stimulating factor (GM-CSF) post-stem cell infusion in patients with solid tumors receiving high-dose combination chemotherapy. Bone Marrow Transplantation, 16(5), 655–661.

Chicago

Sosman, J A, P J Stiff, R A Bayer, J Peliska, D J Peace, S Loutfi, W Stock, et al. 1995. “A Phase I Trial of Interleukin 3 (IL-3) Pre-Bone Marrow Harvest with Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Post-Stem Cell Infusion in Patients with Solid Tumors Receiving High-Dose Combination Chemotherapy.” Bone Marrow Transplantation 16 (5): 655–61. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=8547862&authtype=sso&custid=ns315887.